In summary, while Gómez Delgado et al. provide observations linking FH desialylation to complement dysregulation and SP-HUS pathogenesis, the lack of controls to exclude residual neuraminidase activity undermines their functional claim. This evidence concerns the gene FH and hemolytic-uremic syndrome.